More about High-Yield Cash Accounts with M1
Brokerage Accounts
Retirement Accounts
Other Accounts
Quotes are delayed by 15 minutes.
1D
1W
1M
3M
6M
YTD
1Y
2Y
5Y
ALL
Market cap
$51.16B
EPS
5.08
P/E ratio
33.5
Price to sales
6.52
Dividend yield
0.562%
Beta
1.207033
Previous close
$177.49
Today's open
$177.18
Day's range
$176.77 - $182.99
52 week range
$108.35 - $182.99
show more
CEO
Padraig Mcdonnell
Employees
18000
Headquarters
Santa Clara, CA
Exchange
New York Stock Exchange
Shares outstanding
281928854
Issue type
Common Stock
Healthcare
Biotechnology & Life Sciences
Agilent to Announce Fourth-Quarter Fiscal Year 2026 Financial Results on Nov. 23
SANTA CLARA, Calif.--(BUSINESS WIRE)--Agilent Technologies Inc. (NYSE: A) will release financial results for the fourth quarter of fiscal year 2026 after the stock market closes on Monday, Nov. 23. The company will host a conference call to discuss the results at 1:30 p.m. PST the same day.To join the listen-only conference-call webcast, click the link on the Events section of Agilent's Investor Relations website. A recording of the call will also be available on the website for 90 days.About Ag.
Business Wire • 5 hours ago

Parnassus Mid Cap Growth Fund: Q3 2026 Performance Review
The portfolio's outperformance was primarily driven by our holdings in the Health Care sector, which delivered strong returns for the quarter on company-specific catalysts. Information Technology holdings and underweight to the Energy sector detracted from returns. For the year-to-date period, the Fund returned 5.80% (net of fees), outperforming the Russell Midcap Growth Index's 1.01%.
Seeking Alpha • 10 hours ago

Parnassus Mid Cap Fund Q3 2026 Portfolio Review
Cboe Global Markets gained on strong growth across its derivatives, cash equities and data services businesses. Dick's Sporting Goods dropped after a weaker-than-expected quarter and near-term earnings pressures, driven by losses at its recently acquired Foot Locker business. Formula One is a scarce asset: there is only one global championship, and Formula One Group holds the exclusive commercial rights to it.
Seeking Alpha • Oct 28, 2026

Agilent and University of Chicago Launch Center of Excellence for Energy Materials Research
SANTA CLARA, Calif. & CHICAGO--(BUSINESS WIRE)--Agilent Technologies Inc. (NYSE: A), a global leader in analytical and clinical laboratory technologies, and the University of Chicago, one of the world's leading research universities, today announced a scientific collaboration to establish the Agilent Center of Excellence (CoE) for Energy Materials Research. The Agilent CoE will be based at the University of Chicago Pritzker School of Molecular Engineering (UChicago PME) and will support the Ene.
Business Wire • Oct 27, 2026

Carillon Scout Mid Cap Fund Q3 2026 Portfolio Review
MPC benefited from a favorable refining environment. Operating execution under Agilent's multi-year Ignite initiative supported better profitability. FTAI management lowered the outlook for the aviation leasing business.
Seeking Alpha • Oct 28, 2026

Dividend Champion, Contender, And Challenger Highlights: Week October 25
A weekly summary of dividend activity for Dividend Champions, Contenders, and Challengers. Companies that changed their dividends. Companies with upcoming ex-dividend dates.
Seeking Alpha • Oct 24, 2026

Agilent to Acquire Proscia, Advancing AI-Enabled Digital Pathology and Scientific Intelligence
SANTA CLARA, Calif. & PHILADELPHIA--(BUSINESS WIRE)--Agilent Technologies Inc. (NYSE: A) today announced it has entered into a definitive agreement to acquire Proscia®, a provider of digital pathology software for clinical and life-sciences customers, in an all-cash transaction valued at $240 million in cash at closing and up to an additional $30 million based on achieving future performance milestones. Proscia is a leading independent provider of enterprise digital pathology software, serving.
Business Wire • Oct 13, 2026

Is Agilent Technologies (A) Outperforming Other Medical Stocks This Year?
Here is how Agilent Technologies (A) and Concentra Group (CON) have performed compared to their sector so far this year.
Zacks Investment Research • Oct 12, 2026

Dividend Champion, Contender, And Challenger Highlights: Week October 4
A weekly summary of dividend activity for Dividend Champions, Contenders, and Challengers. Companies which changed their dividends. Companies with upcoming ex-dividend dates.
Seeking Alpha • Oct 2, 2026

Agilent Introduces the NovoStation Sample Preparation System for Automated Flow Cytometry Workflows
SANTA CLARA, Calif.--(BUSINESS WIRE)--Agilent Technologies Inc. (NYSE: A) today announced the launch of the NovoStation Sample Preparation System, a new automated platform designed to help laboratories simplify and streamline flow cytometry sample preparation. When paired with a NovoCyte flow cytometer and NovoExpress software, NovoStation offers an integration-ready solution that enables a hands-free sample-to-answer workflow, helping scientists spend less time preparing samples and more time.
Business Wire • Oct 1, 2026

¹ Disclosures

Open an M1 investment account to buy and sell Agilent Technologies Inc. commission-free¹. Build wealth for the long term using automated trading and transfers.